🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Lymphatic Mapping Of Oropharyngeal Cancer

RecruitingNAAges 18 Years - anyAllUniversity College, London
NCT04498221 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

A multi-centre validation study to evaluate whether a new imaging and surgical protocol would work as well as the current gold standard in identifying sentinel nodes in patients with oropharyngeal cancer.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 or over * New diagnosis of OPC - all anatomical subsites and HPV status accepted * Unilateral metastatic nodes equating to AJCC TNM8 clinical staging N1-N2b for P16 negative and N1 for P16 positive patients. Exclusion Criteria: * Suspicious bilateral nodes on imaging * Previous radiotherapy or surgery to the neck * Second primary oropharyngeal tumours * Distant metastasis (e.g. lung, bone) * Pregnancy and lactation * Inability to give informed consent * Allergy to lymphatic tracers
💊

What it tests

  • Imaging procedure
  • Surgical procedure
📍

Where

2 sites
St George's University Hospitals NHS Foundation Trust
London, United Kingdom
University College Hospital
London, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy